- Issuer ticker
-
DYN
- Reported as of
-
24 Apr 2026
- Net transaction value
-
$0
- SEC form
-
4
- Accepted by SEC
-
28 Apr 2026, 16:56:31 UTC
Filing notes and source
Key filing fact
David Charles Lubner filed Form 4 for Dyne Therapeutics, Inc. (DYN) on 28 Apr 2026.
Key facts
- This page summarizes David Charles Lubner's Form 4 filing for Dyne Therapeutics, Inc. (DYN).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 28 Apr 2026, 16:56.
Change
- Previous filing in this sequence was filed on 20 Jan 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001572000
Primary reporting owner
Lubner David Charles
- Relationship
-
Director
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DYN
transaction
Common Stock
Gift
- Transaction value
- Shares
- -53,625
- Change %
- -100%
- Price
-
$0.000000*
- Shares after
- 0
- Date
- 24 Apr 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.